Overall, our results suggest that IL-18 production regulates claudin-2 and REGIIIγ expression and controls intestinal permeability, possibly by AIM2 inflammasome activation in the small intestine, in order to limit gut microbiota translocation to PLNs, which protect against STZ-induced T1D development. Here, IL18 is linked to type 1 diabetes mellitus.